Left icon

Columnist: Adam Bristol, PhD

Adam Bristol, PhD joined Aquilo Partners, a boutique life sciences investment bank, and Aquilo Capital Management, a life science investment fund, in January 2010. From 2007 through 2009, he was an associate at Biotechnology Value Fund, assisting in sourcing, evaluating and managing of private and public life science companies. Adam has worked with the NIH's Commercialization Assistance Program, the UC-Davis's Entrepreneurship Academy and The Michael J. Fox Foundation’s Therapeutic Development Initiative. Adam previously served on the boards of Airmid and Viriome. He is a Kauffman Fellow. Adam completed his postdoctoral training in neurobiology at Stanford University's School of Medicine, received his PhD from Yale University and a BA from the State University of New York at Binghamton.